Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Oncology
Supply Chain
Awards
CRO Awards
Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Praluent
Pharma
Sanofi, Trump, VC capital crunch—Fierce Pharma Asia
Sanofi is pulling Praluent in China. Drug tariffs will reach 250%, Donald Trump said. Southeast Asia is undergoing a venture capital crunch. And more.
Angus Liu
Aug 8, 2025 9:32am
Amgen owes Regeneron $407M after defeat in PCSK9 antitrust suit
May 15, 2025 3:52pm
Sanofi, Regeneron clinch win in PCSK9 patent feud with Amgen
May 18, 2023 3:16pm
FDA says children age 5-11 now eligible for Regeneron's Evkeeza
Mar 22, 2023 10:39am
Amgen hits back at Sanofi, Regeneron in long-running patent feud
Mar 9, 2023 9:38am
Sanofi and Regeneron win Big Pharma support in Amgen patent feud
Feb 13, 2023 11:19am